Our Studies
Medical Research Studies
Precision Research Institute (PRI) offers high-quality clinical research studies. We offer medical research studies in the areas of gastroenterology, internal medicine, women’s health and much more. Click on a study category below to see medical research studies currently looking for participants.
Our Current Studies
PRI Open Protocol Summaries
INDICATION
AGE CRITERIA
DESCRIPTION
Eosinophilic Esophagitis
≥ 18 years
A Randomized, Double-blind, Placebo-Controlled 24-Week Induction Study of APT-1011, followed by a Singlearm Open-label Extension, in Adult Subjects with Eosinophilic Esophagitis.
Ulcerative Colitis
> 18 & up
A Study to Determine the Association Between Genetic Variants and Ex-Vivo Peripheral Blood Mononuclear Cell (PBMC) Activity in Subjects with Diagnosis of Ulcerative Colitis or Crohn’s Disease
Cirrhosis
≥ 18 and ≤70 yrs.
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD) TABLETS FOR THE DELAY OF ENCEPHALOPATHY DECOMPENSATION IN CIRRHOSIS (RED-C)
Observational Study
45 yrs or older
Prospective, multi-center observational study for the clinical validation of the Next Generation test for blood based screening of colorectal cancer.
Cancer Screening Collection Study
≥ 50 and ≤ 80 yrs.
Cancer Screening Collection Study.
UC of the Rectum
≥ 18 yrs.
A Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Safety and Efficacy of Once-Daily and Twice-Daily Dosing of a Novel Hydrocortisone Acetate 90 mg Suppository Formulation Administered with the Sephure® Suppository Applicator in Subjects with Ulcerative Colitis of the Rectum
Diabetic Gastroparesis
18-75 years
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Diabetic Gastroparesis
NASH
> 65 years
Randomize, Double-Blind, Placebo-Controlled, Phase 2 Studies pf siRNA Gene Silencing for the Treatmrnt of Non-Alcoholic Steatohepatitis(NASH) in Participants with Genetic Risk Factors
Chronic Hep B Virus
≥ 18 years
Phase 3 Multi Center, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in HBeAg-negative Nucleos(t)ide Analogue treated Participants with Chronic Hepatitis B Virus (B Well 1)
Cancer Screening Collection Study
45-84
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode (ECLIPSE)
Our Upcoming Studies
PRI Upcoming Protocol Summaries
INDICATION
AGE CRITERIA
DESCRIPTION
Healthy Patient (Implant Procedure)
18-65 yrs.
AN OPEN-LABEL, PHASE 1 STUDY TO EVALUATE THE ENGRAFTMENT OF VC-01TM COMBINATION
PRODUCT IN THE PRE-PERITONEUM AND SUBCUTANEOUS LAYERS OF NORMAL HEALTHY VOLUNTEERS
Observational Study
45 yrs or older
Prospective, multi-center observational study for the clinical validation of the Next Generation test for blood based screening of colorectal cancer.
Anal fissure-Phase: 2b
18-75 yrs.
A study to investigate anal pain reduction with TAVT-119 (amlodipine besylate) gel compared with placebo gel in participants.